156
Participants
Start Date
September 29, 2023
Primary Completion Date
June 19, 2026
Study Completion Date
July 17, 2026
SAR444656 (KT-474)
Oral Tablet
Placebo
Oral Tablet
Investigational Site Number : 2760005, Berlin
Investigational Site Number : 7240004, Cadiz
Investigational Site Number : 3000003, Athens
Investigational Site Number : 4100001, Seongnam-si
UPMC Montefiore- Site Number : 8400009, Pittsburgh
Vial Health - DermDox Dermatology- Site Number : 8400020, Camp Hill
Investigational Site Number : 7240001, Granada
Encore Medical Research - 6600 Taft St- Site Number : 8400005, Hollywood
Sullivan Dermatology- Site Number : 8400003, Miami
Encore Medical Research - Weston- Site Number : 8400010, Weston
Encore Medical Research of Boynton Beach- Site Number : 8400002, Boynton Beach
Moore Clinical Research - Brandon- Site Number : 8400001, Brandon
Investigational Site Number : 7240002, Seville
Investigational Site Number : 2760004, Remscheid
Investigational Site Number : 2760001, Bochum
Dawes Fretzin Clinical Research- Site Number : 8400011, Indianapolis
Investigational Site Number : 7240005, Manises
Dermatology Specialists Research (DS Research) - Indiana- Site Number : 8400012, Clarksville
Investigational Site Number : 2760007, Frankfurt am Main
Investigational Site Number : 2760002, Heidelberg
Investigational Site Number : 2760008, Munich
Clear Dermatology & Aesthetics Center- Site Number : 8400006, Scottsdale
Advanced Dermatology and Cosmetic Care- Site Number : 8400025, Valencia
Clinical Trials Management Services - Thousand Oaks- Site Number : 8400028, Thousand Oaks
Paradigm Clinical Research - San Diego - ClinEdge - PPDS- Site Number : 8400021, San Diego
Cosmetic Dermatology of Orange County- Site Number : 8400024, Anaheim
Investigational Site Number : 2760006, Würzburg
Investigational Site Number : 4100002, Cheonan-si
Investigational Site Number : 1520004, Temuco
Investigational Site Number : 1520001, Las Condes
Investigational Site Number : 1520002, Santiago
Investigational Site Number : 1520003, Independencia
First OC Dermatology - Fountain Valley- Site Number : 8400007, Fountain Valley
ARA Professionals- Site Number : 8400023, Miami
Beth Israel Deaconess Medical Center - 110 Francis St- Site Number : 8400013, Boston
Wayne Health - Dearborn- Site Number : 8400004, Dearborn
Revive Research Institute-1575 W Big Beaver Rd- Site Number : 8400008, Troy
Clinical Research Philadelphia,LLC- Site Number : 8400026, Philadelphia
Dermatology Specialists of Spokane- Site Number : 8400015, Spokane
Investigational Site Number : 1240004, Québec
Investigational Site Number : 2760009, Dessau
Investigational Site Number : 3000001, Pavlos Melas
Investigational Site Number : 3000002, Thessaloniki
Investigational Site Number : 6160006, Wroclaw
Investigational Site Number : 6160002, Wroclaw
Investigational Site Number : 6160005, Lodz
Investigational Site Number : 6160003, Warsaw
Investigational Site Number : 6160007, Katowice
Investigational Site Number : 6160004, Ossy
Investigational Site Number : 4100003, Seongbuk-Gu
Investigational Site Number : 4100004, Seoul
Investigational Site Number : 7240003, Alicante
Lead Sponsor
Collaborators (1)
Kymera Therapeutics, Inc.
INDUSTRY
Sanofi
INDUSTRY